Welcome to Medications.com

Stocks extend gains on M&A activity despite unsettling US ... - AOL Canada

... to $13.25 after the company said it is the target of US federal grand jury investigation into the 2003 commercial launch of its Cardizem heart drug. ...

http://money.aol.ca/article/dolla... | Posted: Wed Feb 27 23:05:18 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea